Literature DB >> 25916516

Pharmacogenomic assessment of Mexican and Peruvian populations.

Sharon Marsh1, Cristi R King, Derek J Van Booven, Jane Y Revollo, Robert H Gilman, Howard L McLeod.   

Abstract

BACKGROUND: Clinically relevant polymorphisms often demonstrate population-specific allele frequencies. Central and South America remain largely uncategorized in the context of pharmacogenomics. MATERIALS &
METHODS: We assessed 15 polymorphisms from 12 genes (ABCB1 3435C>T, ABCG2 Q141K, CYP1B1*3, CYP2C19*2, CYP3A4*1B, CYP3A5*3C, ERCC1 N118N, ERCC2 K751Q, GSTP1 I105V, TPMT 238G>C, TPMT 460G>A, TPMT 719A>G, TYMS TSER, UGT1A1*28 and UGT1A1 -3156G>A) in 81 Peruvian and 95 Mexican individuals.
RESULTS: Six polymorphism frequencies differed significantly between the two populations: ABCB1 3435C>T, CYP1B1*3, GSTP1 I105V, TPMT 460G>A, UGT1A1*28 and UGT1A1 -3156G>A. The pattern of observed allele frequencies for all polymorphisms could not be accurately estimated from any single previously studied population.
CONCLUSION: This highlights the need to expand the scope of geographic data for use in pharmacogenomics studies.

Entities:  

Keywords:  Hispanic; Mexico; Peru; genotype; pharmacogenomics; polymorphism; population

Mesh:

Year:  2015        PMID: 25916516      PMCID: PMC4515450          DOI: 10.2217/pgs.15.10

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  59 in total

1.  Lower frequency of CYP2C9*2 in Mexican-Americans compared to Spaniards.

Authors:  A LLerena; P Dorado; F O'Kirwan; R Jepson; J Licinio; M-L Wong
Journal:  Pharmacogenomics J       Date:  2004       Impact factor: 3.550

2.  Interethnic variability of ERCC2 polymorphisms.

Authors:  C R King; J Yu; R R Freimuth; H L McLeod; S Marsh
Journal:  Pharmacogenomics J       Date:  2005       Impact factor: 3.550

Review 3.  Present status and perspective of pharmacogenetics in Mexico.

Authors:  Patricia Cuautle-Rodríguez; Adrián Llerena; Juan Molina-Guarneros
Journal:  Drug Metabol Drug Interact       Date:  2014

4.  Polymorphism of the thiopurine S-methyltransferase gene in African-Americans.

Authors:  Y Y Hon; M Y Fessing; C H Pui; M V Relling; E Y Krynetski; W E Evans
Journal:  Hum Mol Genet       Date:  1999-02       Impact factor: 6.150

5.  Human genetics. The genetics of Mexico recapitulates Native American substructure and affects biomedical traits.

Authors:  Andrés Moreno-Estrada; Christopher R Gignoux; Juan Carlos Fernández-López; Fouad Zakharia; Martin Sikora; Alejandra V Contreras; Victor Acuña-Alonzo; Karla Sandoval; Celeste Eng; Sandra Romero-Hidalgo; Patricia Ortiz-Tello; Victoria Robles; Eimear E Kenny; Ismael Nuño-Arana; Rodrigo Barquera-Lozano; Gastón Macín-Pérez; Julio Granados-Arriola; Scott Huntsman; Joshua M Galanter; Marc Via; Jean G Ford; Rocío Chapela; William Rodriguez-Cintron; Jose R Rodríguez-Santana; Isabelle Romieu; Juan José Sienra-Monge; Blanca del Rio Navarro; Stephanie J London; Andrés Ruiz-Linares; Rodrigo Garcia-Herrera; Karol Estrada; Alfredo Hidalgo-Miranda; Gerardo Jimenez-Sanchez; Alessandra Carnevale; Xavier Soberón; Samuel Canizales-Quinteros; Héctor Rangel-Villalobos; Irma Silva-Zolezzi; Esteban Gonzalez Burchard; Carlos D Bustamante
Journal:  Science       Date:  2014-06-12       Impact factor: 47.728

6.  Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5'-terminal regulatory region of the human gene for thymidylate synthase.

Authors:  N Horie; H Aiba; K Oguro; H Hojo; K Takeishi
Journal:  Cell Struct Funct       Date:  1995-06       Impact factor: 2.212

Review 7.  An historical perspective on "The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus".

Authors:  Kenneth K Kidd; Andrew J Pakstis; Libing Yun
Journal:  Hum Genet       Date:  2013-10-27       Impact factor: 4.132

8.  Genetic ancestry influences asthma susceptibility and lung function among Latinos.

Authors:  Maria Pino-Yanes; Neeta Thakur; Christopher R Gignoux; Joshua M Galanter; Lindsey A Roth; Celeste Eng; Katherine K Nishimura; Sam S Oh; Hita Vora; Scott Huntsman; Elizabeth A Nguyen; Donglei Hu; Katherine A Drake; David V Conti; Andres Moreno-Estrada; Karla Sandoval; Cheryl A Winkler; Luisa N Borrell; Fred Lurmann; Talat S Islam; Adam Davis; Harold J Farber; Kelley Meade; Pedro C Avila; Denise Serebrisky; Kirsten Bibbins-Domingo; Michael A Lenoir; Jean G Ford; Emerita Brigino-Buenaventura; William Rodriguez-Cintron; Shannon M Thyne; Saunak Sen; Jose R Rodriguez-Santana; Carlos D Bustamante; L Keoki Williams; Frank D Gilliland; W James Gauderman; Rajesh Kumar; Dara G Torgerson; Esteban G Burchard
Journal:  J Allergy Clin Immunol       Date:  2014-10-06       Impact factor: 10.793

9.  Bayesian inferences suggest that Amazon Yunga Natives diverged from Andeans less than 5000 ybp: implications for South American prehistory.

Authors:  Marilia O Scliar; Mateus H Gouveia; Andrea Benazzo; Silvia Ghirotto; Nelson J R Fagundes; Thiago P Leal; Wagner C S Magalhães; Latife Pereira; Maira R Rodrigues; Giordano B Soares-Souza; Lilia Cabrera; Douglas E Berg; Robert H Gilman; Giorgio Bertorelle; Eduardo Tarazona-Santos
Journal:  BMC Evol Biol       Date:  2014-09-30       Impact factor: 3.260

10.  Prevalence of TPMT and ITPA gene polymorphisms and effect on mercaptopurine dosage in Chilean children with acute lymphoblastic leukemia.

Authors:  Mauricio J Farfan; Carolina Salas; Cristina Canales; Felipe Silva; Milena Villarroel; Katherine Kopp; Juan P Torres; María E Santolaya; Jorge Morales
Journal:  BMC Cancer       Date:  2014-04-28       Impact factor: 4.430

View more
  7 in total

1.  Exploring Variation in Known Pharmacogenetic Variants and its Association with Drug Response in Different Mexican Populations.

Authors:  Vanessa Gonzalez-Covarrubias; José Jaime Martínez-Magaña; Regina Coronado-Sosa; Beatriz Villegas-Torres; Alma D Genis-Mendoza; Pablo Canales-Herrerias; Humberto Nicolini; Xavier Soberón
Journal:  Pharm Res       Date:  2016-07-07       Impact factor: 4.200

2.  Genetic variability among Mexican Mestizo and Amerindian populations based on three ABCB1 polymorphisms.

Authors:  Alma Faviola Favela-Mendoza; Héctor Rangel-Villalobos; Ingrid Fricke-Galindo; Alberto Ortega-Vázquez; Gabriela Martínez-Cortés; Marisol López-López
Journal:  Mol Biol Rep       Date:  2018-10-13       Impact factor: 2.316

3.  IL1A rs1800587 associates with chronic noncrisis pain in sickle cell disease.

Authors:  Xiaoyu Hu; Ellie H Jhun; Yingwei Yao; Ying He; Robert E Molokie; Diana J Wilkie; Zaijie J Wang
Journal:  Pharmacogenomics       Date:  2016-11-24       Impact factor: 2.533

4.  High frequency of mutant thiopurine S-methyltransferase genotypes in Mexican patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Mireya Ramirez-Florencio; Silvia Jiménez-Morales; Rosa Elda Barbosa-Cobos; Daniela Josabeth López-Cano; Julian Ramírez-Bello
Journal:  Clin Rheumatol       Date:  2017-12-20       Impact factor: 2.980

5.  Prevalence of pain-related single nucleotide polymorphisms in patients of African origin with sickle cell disease.

Authors:  Ellie H Jhun; Yingwei Yao; Ying He; A Kyle Mack; Diana J Wilkie; Robert E Molokie; Zaijie Jim Wang
Journal:  Pharmacogenomics       Date:  2015-11-10       Impact factor: 2.533

6.  Variation in Actionable Pharmacogenetic Markers in Natives and Mestizos From Mexico.

Authors:  Vanessa Gonzalez-Covarrubias; Marlet Morales-Franco; Omar F Cruz-Correa; Angélica Martínez-Hernández; Humberto García-Ortíz; Francisco Barajas-Olmos; Alma Delia Genis-Mendoza; José Jaime Martínez-Magaña; Humberto Nicolini; Lorena Orozco; Xavier Soberón
Journal:  Front Pharmacol       Date:  2019-10-10       Impact factor: 5.810

7.  Comparison of Eight Technologies to Determine Genotype at the UGT1A1 (TA)n Repeat Polymorphism: Potential Clinical Consequences of Genotyping Errors?

Authors:  Tristan M Sissung; Roberto H Barbier; Douglas K Price; Teri M Plona; Kristen M Pike; Stephanie D Mellott; Ryan N Baugher; Gordon R Whiteley; Daniel R Soppet; David Venzon; Arlene Berman; Arun Rajan; Giuseppe Giaccone; Paul Meltzer; William D Figg
Journal:  Int J Mol Sci       Date:  2020-01-30       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.